Source: National Institutes of Health (NIH) | May 18, 2016

Large-Scale HIV Vaccine Trial to Launch in South Africa

NIH-Funded Study Will Test Safety, Efficacy of Vaccine Regimen

An early-stage HIV vaccine clinical trial in South Africa has determined that an investigational vaccine regimen is safe and generates comparable immune responses to those reported in a landmark 2009 study showing that a vaccine can protect people from HIV infection. Consequently, the National Institute of Allergy and Infectious Diseases…